These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15489832)
1. [Expert consensus document on the use of antiplatelet agents]. Gratsianskiĭ NA Kardiologiia; 2004; 44(3):75. PubMed ID: 15489832 [No Abstract] [Full Text] [Related]
2. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice. Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714 [No Abstract] [Full Text] [Related]
3. Practical approach to incorporating new studies and guidelines for antiplatelet therapy in the management of patients with non-ST-segment elevation acute coronary syndrome. Boden WE Am J Cardiol; 2004 Jan; 93(1):69-72. PubMed ID: 14697469 [No Abstract] [Full Text] [Related]
4. [Impact of GP IIb/IIIa antagonists in interventional cardiology]. Scheller B; Hennen B; Böhm M; Nickenig G Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800 [No Abstract] [Full Text] [Related]
5. Antiplatelet therapy--Part I. Goodnight SH; Coull BM; McAnulty JH; Taylor LM West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125 [TBL] [Abstract][Full Text] [Related]
6. [Platelet antiaggregants in the treatment of arterial thrombosis]. Ferlito S Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283 [TBL] [Abstract][Full Text] [Related]
7. [Acute coronary syndromes without ST-elevation -- treatment]. Weber M; Hamm C Dtsch Med Wochenschr; 2003 Feb; 128(6):273-6. PubMed ID: 12571797 [No Abstract] [Full Text] [Related]
8. Antiplatelet drugs in cardiovascular diseases. Weston C; Rao U Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893 [TBL] [Abstract][Full Text] [Related]
9. [Expert consensus document on the use of antiplatelet agents]. Patrono C; Bachmann F; Baigent C; Bode C; De Caterina R; Charbonnier B; Fitzgerald D; Hirsh J; Husted S; Kvasnicka J; Montalescot G; García Rodríguez LA; Verheugt F; Vermylen J; Wallentin L; Rev Esp Cardiol; 2004 Oct; 57(10):963-80. PubMed ID: 15469794 [No Abstract] [Full Text] [Related]
10. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies. Mohammad RA; Goldberg T; Dorsch MP; Cheng JW Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100 [TBL] [Abstract][Full Text] [Related]
11. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. Tran H; Anand SS JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585 [TBL] [Abstract][Full Text] [Related]
12. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)? Olson J; Huntington J J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713 [No Abstract] [Full Text] [Related]
13. [The DAPT study]. Pavasini R; Campo G; Limbruno U; De Servi S G Ital Cardiol (Rome); 2015; 16(7-8):393-8. PubMed ID: 26228607 [No Abstract] [Full Text] [Related]
14. ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina. Lip GY; Chin BS; Prasad N BMJ; 2002 Nov; 325(7375):1287-9. PubMed ID: 12458252 [No Abstract] [Full Text] [Related]
15. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?]. MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200 [No Abstract] [Full Text] [Related]
16. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy]. Marcucci R G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874 [No Abstract] [Full Text] [Related]
17. [Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction]. Koziński M; Grześk G; Kubica J Kardiol Pol; 2012; 70(2):206-12. PubMed ID: 22427098 [No Abstract] [Full Text] [Related]